Literature DB >> 12840879

Study on relationship between anticardiolipin antibody and cerebrovascular diseases.

C Liu1, Y Xia, S Sun, G Yuan, E Tong.   

Abstract

Serum anticardiolipin antibody (ACA) was measured in 91 patients with cerebral infarction (CI), 42 patients with cerebral hemorrhage (CH) and 30 healthy controls. The results showed that the ACA in CI and CH patients was significantly higher than in controls and IgG-ACA was the most important isotype. Stroke in ACA positive group tended to be recurrent and of multi-focuses. Positive rate of IgG-ACA reached its peak within the first week after stroke onset. The results suggested that ACA was an independent risk factor in CI and CH and might be valuable in stroke prediction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12840879     DOI: 10.1007/bf02895599

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  8 in total

1.  Antiphospholipid antibodies: origin, specificity, and mechanism of action.

Authors:  R L Brey; B M Coull
Journal:  Stroke       Date:  1992-02       Impact factor: 7.914

2.  Prospective study of anticardiolipin antibodies in stroke.

Authors:  M J Kushner
Journal:  Stroke       Date:  1990-02       Impact factor: 7.914

3.  Patients with antiphospholipid antibodies: CT and MR findings of the brain.

Authors:  J M Provenzale; D P Barboriak; N B Allen; T L Ortel
Journal:  AJR Am J Roentgenol       Date:  1996-12       Impact factor: 3.959

4.  Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome.

Authors:  S R Levine; R L Brey; K L Sawaya; L Salowich-Palm; J Kokkinos; B Kostrzema; M Perry; S Havstad; J Carey
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

5.  Value of immunologic testing in stroke patients. A prospective multicenter study.

Authors:  J Montalbán; J Rio; M Khamastha; A Davalos; M Codina; G T Swana; M E Calcagnotto; J Sumalla; S Mederer; A Gil
Journal:  Stroke       Date:  1994-12       Impact factor: 7.914

6.  Anticardiolipin antibodies in acute non-hemorrhagic stroke seen within six hours after onset.

Authors:  M Camerlingo; L Casto; B Censori; G Drago; A Frigeni; B Ferraro; M C Servalli; E Radice; A Mamoli
Journal:  Acta Neurol Scand       Date:  1995-07       Impact factor: 3.209

7.  Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group.

Authors: 
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

8.  Anticardiolipin antibodies in an unselected stroke population.

Authors:  K W Muir; I B Squire; W Alwan; K R Lees
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.